HEPATIC ENCEPHALOPATHY
PORTAL SYSTEMIC ENCEPHALOPATHY (PSE)
Background:
PSE is defined as a change in mentation in a patient with cirrhosis and portal hypertension
Cause of PSE remains contentious (? Ammonia, GABA, Mercaptans)
CNS lesion is Astrocyte hyperplasia (Alzheimer type II astrocyte change)
Stages of Hepatic Encephalopathy
STAGE MENTAL STATUS PHYSICAL EXAM




I Euphoria/Depression, Day-Night Sleep reversal, Mild asterixis (may be absent)
poor concentration, mild confusion, slurred speech
II Increased drowsiness, confusion, inability to sustain Significant Asterixis,
Concentration Brisk reflexes
III Marked confusion, arousable but sleeping continuously Asterixis, clonus
IV Minimally responsive to painful stimuli Patient may “posture” to pain
Asterixis absent
Risk factors:
High protein load (i.e. GI bleeding, increase in protein intake)
SBP
Infection
Constipation
Hypokalemia
Narcotics, Benzodiazepines
Liver failure
Post TIPS
Portal vein thrombosis
Treatment:
Cure constipation (enema, Mg Citrate, MOM)
Consider Branched chain amino acid nutritional supplements (Hepatic Aid/Nutrahep/Hepatamine)
Lactulose 30 cc po every 1-2 hrs until soft bowel movement, titrate to achieve 2-3 soft bowel movements a day
Neomycin 500mg po q 6
Use with caution in the setting of renal insufficiency
Flagyl 500 mg po q 6
Zinc 220 mg po tid
L-carnitine 250 mg po tid
Liver transplantation if refractory to therapy
Hemodialyis (for cases with significant hyper-Ammonemia associated with Urea cycle abnormalities )
Sodium Benzoate (for Pediatrics)
If PSE is grade III to IV, particularly in the setting of fulminant liver failure, may consider
Bioartificial liver/extra-corporeal liver assist device (see section on Fulminant liver failure)
Urgent liver transplantation